miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Retraction]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112477/
https://www.ncbi.nlm.nih.gov/pubmed/37081943
http://dx.doi.org/10.2147/IJN.S415737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112477/
https://www.ncbi.nlm.nih.gov/pubmed/37081943
http://dx.doi.org/10.2147/IJN.S415737

Ejemplares similares